Loading...
Back to narrative

507717: Nagpur Formulation Plant Expansion Will Drive Long-Term Upside Potential

507717: New Nagpur Plant And Higher Margins Will Drive Future Upside

507717 logo
507717
AnalystConsensusTarget
Not Invested
Published 09 Feb 2025

Update shared on 16 Dec 2025

Fair value Decreased 1.91%
Previous
n/a
n/a
AnalystConsensusTarget's Fair Value
n/a
Loading
1Y
-21.8%
7D
-0.2%

Analysts have nudged their fair value estimate for Dhanuka Agritech down slightly from ₹1,638 to about ₹1,607 per share, reflecting tempered revenue growth expectations, partially offset by a modestly higher projected profit margin and a slightly lower assumed future P E multiple.

What's in the News

  • Board meeting scheduled on October 31, 2025, at 11:00 IST to review financial results for the quarter and half year ended September 30, 2025 (company filing)
  • Board to consider purchase of land in Nagpur, Maharashtra, for setting up a new formulation plant, indicating planned capacity expansion (company filing)
  • Outcome of the October 31, 2025 board meeting expected to provide clarity on near term growth, capex, and margin trajectory (company filing)

Valuation Changes

  • The fair value estimate was reduced slightly from ₹1,638 to about ₹1,607 per share, reflecting marginally softer assumptions.
  • The discount rate edged down fractionally from 13.36 percent to about 13.35 percent, implying a marginally lower perceived risk profile.
  • Revenue growth was trimmed from roughly 13.97 percent to about 12.96 percent, indicating more conservative top line expectations.
  • The net profit margin was raised modestly from about 13.64 percent to roughly 14.01 percent, pointing to a slightly more optimistic margin outlook.
  • The future P/E multiple was lowered slightly from about 26.41x to around 25.90x, suggesting a marginally more cautious valuation stance.

Have other thoughts on Dhanuka Agritech?

Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.

Create Narrative

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.